Search by Drug Name or NDC

    NDC 00944-4627-01 ADYNOVATE Details

    ADYNOVATE

    ADYNOVATE is a KIT in the PLASMA DERIVATIVE category. It is labeled and distributed by Takeda Pharmaceuticals Amercia, Inc.. The primary component is .

    Product Information

    NDC 00944-4627
    Product ID 0944-4627_215d2368-3d55-4bf5-adce-cc4d43c566f6
    Associated GPIs 85100010402145
    GCN Sequence Number 077114
    GCN Sequence Number Description antihemo.FVIII,full length peg VIAL 1500 (+/-) INTRAVEN
    HIC3 M0E
    HIC3 Description ANTIHEMOPHILIC FACTORS
    GCN 43013
    HICL Sequence Number 042832
    HICL Sequence Number Description ANTIHEMOPHILIC FACTOR (FVIII) RECOMBINANT, FULL LENGTH, PEG
    Brand/Generic Brand
    Proprietary Name ADYNOVATE
    Proprietary Name Suffix n/a
    Non-Proprietary Name Antihemophilic Factor (Recombinant) PEGylated
    Product Type PLASMA DERIVATIVE
    Dosage Form KIT
    Route n/a
    Active Ingredient Strength n/a
    Active Ingredient Units n/a
    Substance Name n/a
    Labeler Name Takeda Pharmaceuticals Amercia, Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA125566
    Listing Certified Through 2025-12-31

    Package

    NDC 00944-4627-01 (00944462701)

    NDC Package Code 0944-4627-01
    Billing NDC 00944462701
    Package 1 KIT in 1 CARTON (0944-4627-01) / 1 CONTAINER in 1 KIT (0944-4627-02) / 1 KIT in 1 CONTAINER (0944-4627-03) * 5 mL in 1 VIAL, GLASS (0944-4141-01) * 2 mL in 1 VIAL, GLASS (64764-514-02)
    Marketing Start Date 2015-11-13
    NDC Exclude Flag N
    Pricing Information N/A